IMA
ImageneBioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
IMA vs peer average
72/100
IMA vs. peer average (C vs. D)
Grade spread
C 1 · D 4 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
INMB is the first available peer comparator.
Packet-selected similar-market-cap biotech with unverified clinical and indication overlap; a loose risk comparator, not a direct peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMA
ImageneBio
INMB
INmune Bio
Grade
C
F
Momentum
58
16
Value
56
41
Sentiment
57
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs INMB
IMA / INMB
Grade Position
Above peers
IMA vs. peer average (C vs. D)
72/100
Momentum
58
IMAValue
56
IMASentiment
57
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMA
INMB is the first peer returned for this comparison set.